Shares of Albemarle Co. (NYSE:ALB – Get Free Report) have been given an average rating of “Hold” by the twenty-two ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $115.74.
A number of brokerages have issued reports on ALB. Royal Bank of Canada lifted their price target on shares of Albemarle from $108.00 to $133.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. Wells Fargo & Company boosted their target price on Albemarle from $100.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 8th. KeyCorp cut their price target on Albemarle from $132.00 to $127.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. Oppenheimer lowered their target price on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, Robert W. Baird boosted their price target on shares of Albemarle from $79.00 to $103.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 18th.
Check Out Our Latest Analysis on Albemarle
Insider Activity
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of ALB. Charles Schwab Investment Management Inc. grew its position in shares of Albemarle by 38.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,020,590 shares of the specialty chemicals company’s stock worth $96,660,000 after buying an additional 282,194 shares in the last quarter. Empower Advisory Group LLC grew its holdings in Albemarle by 28.7% during the 3rd quarter. Empower Advisory Group LLC now owns 705,719 shares of the specialty chemicals company’s stock worth $66,839,000 after acquiring an additional 157,319 shares in the last quarter. MBB Public Markets I LLC increased its position in Albemarle by 392.6% during the 2nd quarter. MBB Public Markets I LLC now owns 7,916 shares of the specialty chemicals company’s stock valued at $756,000 after purchasing an additional 6,309 shares during the period. Vest Financial LLC raised its holdings in shares of Albemarle by 32.4% in the 3rd quarter. Vest Financial LLC now owns 521,537 shares of the specialty chemicals company’s stock valued at $49,395,000 after purchasing an additional 127,549 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its holdings in shares of Albemarle by 28.5% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 423,049 shares of the specialty chemicals company’s stock valued at $40,067,000 after purchasing an additional 93,718 shares in the last quarter. 92.87% of the stock is currently owned by hedge funds and other institutional investors.
Albemarle Trading Down 1.0 %
Shares of ALB opened at $88.29 on Wednesday. Albemarle has a 1 year low of $71.97 and a 1 year high of $151.79. The company has a 50 day simple moving average of $100.40 and a two-hundred day simple moving average of $95.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.44 and a quick ratio of 1.58. The firm has a market cap of $10.38 billion, a P/E ratio of -5.27 and a beta of 1.56.
Albemarle Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, December 13th will be paid a $0.405 dividend. The ex-dividend date is Friday, December 13th. This represents a $1.62 dividend on an annualized basis and a yield of 1.83%. Albemarle’s payout ratio is -9.67%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
- Five stocks we like better than Albemarle
- What is the Euro STOXX 50 Index?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Market Cap Calculator: How to Calculate Market Cap
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Upcoming IPO Stock Lockup Period, Explained
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.